MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Deep Learning Approaches for Recognition of Parkinson’s Disease Patients through Handwriting, Audio and Video Analysis

    JT. Li, Y. Qu, HL. Gao, Z. Min, ZJ. Mao, P. Xiao, X. Chen, LH. Wei, Q. Yu, Y X. Hao, Z. Xue, YJ. Xiong (Wuhan, China)

    Objective: The aim of this study was to build PD diagnostic models based on deep learning approaches using technologies including handwriting identification, automatic speech recognition…
  • 2022 International Congress

    Exploring the impact of central cholinergic dysfunction on cognitive functioning in patients of Parkinson’s disease with and without REM sleep behavior disorder

    A. Bhattacharya, K. Udupa, N. Kamble, M. Gothwal, S. Hegde, R. Yadav, PK. Pal (Bengaluru, India)

    Objective: This paper aims at establishes the presence of significantly higher cholinergic dysfunction in patients using short latency afferent inhibition. Background: Parkinson's disease (PD) is…
  • 2022 International Congress

    PLA2G6-related dystonia-parkinsonism in identical twins manifesting at an advanced age: a case report and review of the literature.

    D. Sugar, K. Kompoliti (Chicago, USA)

    Objective: To report a rare presentation of a rare disease and illustrate the range of phenotype seen in PLA2G6-associated dystonia-parkinsonism (PLADP). Background: PLA2G6 encodes a…
  • 2022 International Congress

    Effectiveness of a home-based exercise program on gait characteristics in an individual with Parkinson’s disease over a one-year period: A case study

    F. Khobkhun, P. Srivanitchapoom, J. Richards (Nakhon Pathom, Thailand)

    Objective: The purpose of this study was to explore the case history of an individual with Parkinson’s disease (PD) who used a home-based exercise programme…
  • 2022 International Congress

    Isolated ZIC4 antibody associated paraneoplastic cerebellar degeneration

    A. Agarwal, A. Garg, A. Srivastava (New Delhi, India)

    Objective: Anti-ZIC4 antibodies have recently been associated with paraneoplastic cerebellar degeneration (PCD) and are usually associated with small cell carcinoma lung. However, most of the…
  • 2022 International Congress

    Machine learning-based classification of SCA1, SCA2, and Healthy controls using graph features

    A. Indoria, S. Bhardwaj, AS. Sunny, S. Hegde, N. Kamble, J. Saini, R. Yadav, PK. Pal, RD. Bharath (Bengaluru, India)

    Objective: To differentiate genetic variants of spinocerebellar ataxia (SCA1 and SCA2) and healthy controls using machine learning on resting-state functional Magnetic Resonance Imaging graph features.…
  • 2022 International Congress

    Plasma p-Tau181 and p-Tau231 in Parkinson’s Disease

    MC. Gonzalez, NJ. Ashton, A. Pilitto, A. Padovani, B. Fernandes Gomes, DA. Tovar-Rios, F. Blanc, A. Lemstra, C. Paquet, C. Abdelnour, M. Boada, L. Bonanni, R. Vandenberghe, K. Blennow, H. Zetterberg, D. Aarsland (Stavanger, Norway)

    Objective: To explore whether plasma phosphorylated tau (p-Tau) 181 and p-Tau231 levels are associated with cognition in a Parkinson’s Disease (PD) cohort. Background: We recently…
  • 2022 International Congress

    Second Project: The feasibility and efficacy of virtual visits compared to in-person visits for management of Parkinson’s disease. A pilot, international, longitudinal, multicenter trial (NCT04695353).

    A. García-Bustillo, O. Ojo, N. Okubadejo, JH. Ahn, J. Youn, E. Eldayem, A. Shalash, A. Cardozo, Z. Aldaajani, J. Bajwa, M. Spindler, M. Shackleford, Z. Mari, E. Cubo (Burgos, Spain)

    Objective: To investigate the feasibility and efficacy of virtual visits for Parkinson's Disease (PD) compared to in-person visits. Background: Considering the limited access to specialists…
  • 2022 International Congress

    Type 2 diabetes-associated transcriptomic changes in Parkinson’s disease and non-neurodegenerative control brains.

    P. Cullinane, E. de Pablo-Fernandez, K. Ebanks, Z. Jaunmuktane, T. Warner (London, United Kingdom)

    Objective: To evaluate the effect of type 2 diabetes (T2D) on gene transcription in Parkinson’s disease (PD) and non-neurodegenerative control brains. Background: People with T2D…
  • 2022 International Congress

    Dynamical modulations of low frequency deep brain stimulation on axial symptoms in Parkinson’s disease

    Y. Thenaisie, L. Comeliau, C. Varescon, L. Asboth, M. Castro, J. Bally, G. Courtine, J. Bloch, E. Martin Moraud (Lausanne, Switzerland)

    Objective: First, we aimed to evaluate the optimal contact to address axial symptoms with low frequency deep brain stimulation (LFS). Second, we aimed to evaluate…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley